triazoles has been researched along with Psychoses in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dixit, TS; Elased, KM; Lucot, JB; Sharma, AN | 1 |
| Köhnlein, O; Lutz, R; Messer, T; Schmauss, M | 1 |
| Puzantian, T; Shaw, RJ | 1 |
3 other study(ies) available for triazoles and Psychoses
| Article | Year |
|---|---|
Antipsychotic-like effect of GLP-1 agonist liraglutide but not DPP-IV inhibitor sitagliptin in mouse model for psychosis.
Topics: Animals; Antipsychotic Agents; Apomorphine; Disease Models, Animal; Dopamine Agonists; Glucagon-Like Peptide 1; Liraglutide; Male; Mice; Psychotic Disorders; Pyrazines; Sitagliptin Phosphate; Statistics, Nonparametric; Triazoles | 2013 |
[Determining serum concentrations of the modern antipsychotic quetiapin: clinical relevance in therapeutic drug monitoring].
Topics: Adult; Aged; Antipsychotic Agents; Brief Psychiatric Rating Scale; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Female; Humans; Male; Middle Aged; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Statistics as Topic; Triazoles | 2004 |
Nefazodone and symptoms suggesting neurotoxicity: a case report.
Topics: Adult; Antidepressive Agents, Second-Generation; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Male; Nervous System Diseases; Piperazines; Psychotic Disorders; Triazoles | 1996 |